A modified human ELISPOT assay to detect specific responses to primary tumor cell targets
<p>Abstract</p> <p>Background</p> <p>The desired outcome of cancer vaccination is to induce a potent T cell response which can specifically recognize and eliminate autologous tumor cells <it>in vivo</it>. Accordingly, immunological assays that demonstrate recognition of native tumor cells (tumor-spe...
Guardat en:
| Autors principals: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2004-03-01
|
| Col·lecció: | Journal of Translational Medicine |
| Accés en línia: | http://www.translational-medicine.com/content/2/1/9 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|